Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 357 | 510 | 284 | 445 | 406 |
| Gross Profit | 357 | 510 | 284 | 445 | 406 |
| Operating Expenses | 15,158 | 17,974 | 16,028 | 15,587 | 14,231 |
| Operating Income | -14,801 | -17,464 | -15,744 | -15,142 | -13,825 |
| Interest Expense | 2,080 | 1,681 | 1,518 | 1,242 | 1,670 |
| Other Income | -2,493 | 1,276 | -1,050 | 2,407 | -8,027 |
| Pre-tax Income | -19,374 | -17,869 | -18,312 | -13,977 | -23,522 |
| Net Income Continuous | -19,374 | -17,869 | -18,312 | -13,977 | -23,522 |
| Net Income | $-19,374 | $-17,869 | $-18,312 | $-13,977 | $-23,522 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.02 | -0.02 | N/A |
| EBITDA(a) | $-13,805 | $-16,539 | $-14,740 | $-14,352 | $-12,679 |